Background In COVID-19 patients, undetected co-infections may have severe clinical
implications associated with increased hospitalization, varied treatment approaches and …

Background Co‐infections, secondary bacterial or fungal infections, are important risk
factors for poor outcomes in viral infections. The prevalence of co‐infection and secondary …

Background: Although coinfection with influenza in COVID-19 patients has drawn
considerable attention, it is still not completely understood whether simultaneously infected …

Objectives In previous influenza pandemics, bacterial co-infections have been a major
cause of mortality. We aimed to evaluate the burden of co-infections in patients with COVID …

Background and Aim: Co-infection of COVID-19 with other respiratory pathogens which may
complicate the diagnosis, treatment, and prognosis of COVID-19 emerge new concern. The …

Case reports of patients infected with COVID-19 and influenza virus (“flurona”) have raised
questions around the prevalence and severity of coinfection. Using data from HHS Protect …

Background With the easing of COVID-19 non-pharmaceutical interventions, the resurgence
of both influenza and respiratory syncytial virus (RSV) was observed in several countries …

Purpose The goal of our review was to gather information on the most important community-
acquired and hospital-acquired co-infections among coronavirus disease 2019 (COVID-19) …

Objective To delineate the clinical characteristics of critically ill COVID-19 patients co-
infected with influenza. Methods This study included adult patients with laboratory-confirmed …

Background It has been recognised for a considerable time-period, that viral respiratory
infections predispose patients to bacterial infections, and that these co-infections have a …